Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Operating lease payments due — Year 5 by Year
Operating lease payments due — Year 5 ($M) ($M)
Pfizer Operating lease payments due — Year 5: $234M in FY2025, down 2.1% from a year earlier.
Latest, FY2025
234
Period ended Dec 31, 2025
Change on a year earlier
-2.1%
239 in FY2024
History
7 years
Since FY2019
Sources
7
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Form 10-K Lease Commitments Footnote.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Operating lease payments due — Year 5 ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 234 | -2.1% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 239 | -8.8% | Form 10-K (filed 2025-02-27) ↗ |
| FY2023 | Dec 31, 2023 | 262 | +6.5% | Form 10-K (filed 2024-02-22) ↗ |
| FY2022 | Dec 31, 2022 | 246 | +13.4% | Form 10-K (filed 2023-02-23) ↗ |
| FY2021 | Dec 31, 2021 | 217 | +58.4% | Form 10-K (filed 2022-02-24) ↗ |
| FY2020 | Dec 31, 2020 | 137 | +41.2% | Form 10-K (filed 2021-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 97 | – | Form 10-K (filed 2020-02-27) ↗ |
Cite this data
StockData. (2026). Pfizer Operating lease payments due — Year 5 ($M), annual FY2019–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/lease-due-y5
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.